Femtech Insider’s Post

📚 𝐔𝐧𝐥𝐨𝐜𝐤 𝐭𝐡𝐞 𝐏𝐨𝐰𝐞𝐫 𝐨𝐟 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐨𝐠𝐞𝐧𝐨𝐦𝐢𝐜𝐬: 𝐓𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 📚 "Pharmacogenomics stands as the cornerstone of precision medicine, representing an academic pursuit and a practical approach to individualized healthcare." - Zeina Al-Mahayri, Ph.D. Discover practical strategies for integrating this innovative approach into primary care settings. Don't miss this valuable opportunity to stay ahead in the era of precision medicine. 🚀 Click the link to read the full article: https://lnkd.in/dMfsFpAG The Golden Helix Foundation #Pharmacogenomics #PersonalizedMedicine #healthcareinnovation #PatientCare #precisionmedicine #genetictesting #MedicalAdvancements #primarycare #healtheducation #mededgemea

GlobalData Plc highlights the challenge of low drug compliance in Osteoperosis. With painless fractures complicating early detection, patient education and adherence are crucial. #Osteoporosis | #Healthcare | #TreatmentAdherence Read more about it and much more on health HQ's website here: https://lnkd.in/ePW8YEvd

The future of #healthcare is here! Discover how digital therapeutics are shaping modern medicine 👉 https://bit.ly/3XmfCSU #DigitalHealth #HealthcareInnovation

In the latest issue of PME, Matias Ferraris discusses the importance of the patient voice in MS care: https://lnkd.in/e9rwMVrv #pharma #health #PME

Did you know that St. Elizabeth Healthcare is one of a handful of hospitals using pharmacogenomics to determine how patients will respond to medication? Our colleague, Dr. Josiah Allen, shares valuable insights and information about our pharmacogenomics program in this article featured on LINK NKY. #steproud #bestplacetowork #pharmacogenomics #personalizedmedicine #healthcareinnovation https://lnkd.in/ggKFQTdX

Pharmacogenomics #PGx

[ #PinkOctober ] ✨🥼 Accuracy of doses in hospital #pharmacy: a real need 🥼✨ With the steady increase in the number of chemotherapies and the challenge of hospital staff recruitment, it's crucial to find #innovative solutions. 🏥📈 👉 Massive personalized doses? yes, it's possible, and they're prepared BEFORE the patient arrives. 🕒 Result? The stress of waiting is greatly reduced. Imagine having #chemotherapy ready right from the consultation! For pharmacy teams 🥼, it's a massive breath of fresh air. Gone are the days of preparing under pressure. More serenity in their daily work. 🌈 And for the patients? A completely transformed experience where efficiency meets compassion. For everyone - #patients, prescribers, care teams, and pharmacists - it's a revolution in the journey care. 🔄❤️ Share the evolution and visit our website: https://lnkd.in/gaf6YUE! 🔄🌟 #FuturisticPharmacy #OptimisedCare #BreastCancer #Awareness

Nearly half of US adults has hypertension. Because of this, around 650 million prescriptions for blood pressure meds are filled each year. But for many patients, lifestyle changes and medications simply fall short. That gap is where renal denervation, or RDN, aims to offer an alternative for patients in need and those who provide care for them. Last week, Recor Medical's Paradise system became the first FDA approved RDN treatment in the United States. Today's Signal explores the need, solution, evidence, and uncertainty that mark this moment in medical device innovation. It was fun taking a break from the high-level, thematic pieces to write something a bit more targeted. For those of you following this one, I'd love to hear what's on your mind, what I missed, and what else we should know about this [space]. Thanks to all the patients, families, researchers, providers, innovators and investors who made this one possible. Another great example of an "overnight success" ...a decade+ in the making. Recor Medical Sofinnova Partners Mano Iyer Otsuka Holdings Co., Ltd. Ajay Kirtane Columbia University Irving Medical Center NewYork-Presbyterian Hospital Cedars-Sinai FDA LSI Felix Mahfoud Universität des Saarlandes Naomi Fisher Brigham and Women's Hospital Horst Sievert MassDevice Society for Cardiovascular Angiography & Interventions HCPLive TCTMD Lara Barghout Andrew Weiss #medtech #fda #hypertension #research #meddevice #venturecapital #funding #medicaldevices #cardiology #startups #acquisition

🌟 Embracing Pharmacogenomics for Enhanced Long-Term Care 🌟 As the demand for long-term care facilities continues to rise, it is imperative that we explore innovative solutions to improve the quality of life for our elderly patients while also reducing healthcare costs. Today, I want to highlight the importance of offering pharmacogenomics (PGx) testing in these settings and the significant impact it can have on personalized care and financial outcomes. Pharmacogenomics is a field that analyzes an individual's genetic makeup to determine how their body will respond to specific medications. By integrating PGx testing into long-term care facilities, we can tailor medication therapy based on each patient's unique genetic profile. This approach allows us to optimize treatment outcomes, minimize adverse drug reactions, and enhance the overall quality of care. For elderly patients, who are more vulnerable to medication-related complications, PGx testing offers tremendous benefits. By identifying potential drug interactions and adverse reactions early on, we can make informed decisions regarding medication selection and dosing adjustments, reducing the risk of adverse drug events. This personalized approach to medication management enhances the comfort, well-being, and quality of life for our senior community. Implementing PGx testing in long-term care facilities also has the potential to yield significant cost savings. By avoiding adverse drug reactions and unnecessary hospitalizations, we can alleviate the financial burden on individuals and healthcare systems. Personalized medication therapy ensures that patients receive the most appropriate and effective treatment from the start, eliminating the need for costly adjustments and interventions down the line. This not only reduces healthcare costs but also conserves valuable resources that can be redirected towards enhancing overall patient care. By offering PGx testing in long-term care facilities, we can revolutionize medication management and transform the way we provide care to our elderly population. This innovative approach improves patient outcomes, enhances the overall quality of care, and reduces healthcare costs in a meaningful and sustainable manner. I urge all healthcare professionals, administrators, and stakeholders in the long-term care industry to recognize the value of integrating pharmacogenomics into our standard practices. Let us work together to ensure that our elderly patients receive the personalized care they deserve, improving their quality of life and fostering a brighter future for long-term care. #Pharmacogenomics #PersonalizedMedicine #LongTermCare #ElderlyCare #ImprovingQualityofLife #ReducingHealthcareCosts

Nice article on *Digital Therapeutics* in Silicon India Magazine Thanks #Mithun Kumar for the mention in the article, Thanks Silicon India team!! #digitaltherapeutics #digitalmedicine #siliconindia